Gynecologic oncologist Mariam AlHilli, MD, explains recent research, which confirms that women under 40 with endometrial cancer have more favorable prognoses, though are more likely to recur. The study also found that mismatch repair protein deficiency caused by methylation of the gene MLH1 predicted a worse prognosis.